文献速递癫痫认知障碍与痴呆帕金森病与运动障碍

GABRB2相关神经发育障碍的特征分析

Characterization of the GABRB2-Associated Neurodevelopmental Disorders.
PubMed 文献 · Ann Neurol · 2020-12-24

该研究系统评估了25例GABRB2变异个体(17例新报告,8例既往报告补充临床数据),并进行爪蟾卵母细胞功能分析。结果显示GABRB2相关癫痫谱从遗传性全面性癫痫到发育性癫痫性脑病,58%为药物难治性癫痫,84%存在发育障碍,44%有运动障碍;变异聚集于细胞外N端和跨膜域1-3,跨膜域1/2变异表型更重。功能分析证实GABA诱发电流失幅显著降低,支持GABA能抑制丧失为致病机制。

要点

  • GABRB2变异可导致从遗传性全面性癫痫到发育性癫痫性脑病的宽谱表型。
  • 发育障碍和运动障碍是核心特征,分别见于84%和44%的个体。
  • 跨膜域1/2及变构结合位点变异与更严重表型相关。

核心结论

  • GABRB2相关癫痫严重程度范围广,从遗传性全面性癫痫到发育性癫痫性脑病。
  • 发育障碍和运动障碍是GABRB2相关神经发育障碍的关键特征。
  • 表型严重程度因蛋白结构域而异,实验证据支持GABA能抑制丧失为潜在机制。

研究设计与样本

  • 招募并系统评估25例GABRB2变异个体,来自22个家系,其中17例新报告、8例既往报告并补充临床数据。
  • 使用非洲爪蟾卵母细胞模型系统对4个跨膜域1或2变异进行功能分析。

主要发现

  • 58%的个体患有药物难治性癫痫,针对GABA能通路的药物反应不一致。
  • 84%的个体存在发育障碍,范围从轻度智力障碍到严重全面残疾。
  • 44%的个体存在运动障碍,包括舞蹈手足徐动症、肌张力障碍和共济失调。
  • 疾病相关变异聚集于细胞外N端和跨膜域1-3,跨膜域1和2及跨膜域2-3间变构结合位点的变异与更严重表型相关。
  • 4个跨膜域1或2变异(p.Ile246Thr、p.Pro252Leu、p.Ile288Ser、p.Val282Ala)的功能分析显示GABA诱发电流失幅强烈降低。

关键数值与推荐

  • 药物难治性癫痫占58%(25例个体中)。
  • 发育障碍占84%,运动障碍占44%。
  • 功能分析显示4个特定变异导致GABA诱发电流失幅强烈降低。

临床怎么用

  • 对GABRB2变异相关癫痫患者应评估发育障碍和运动障碍,并注意药物难治性可能。
  • 变异所在蛋白结构域(尤其是跨膜域1/2及变构结合位点)可提示表型严重程度。
  • 靶向GABA能通路的药物反应不一致,需个体化治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to characterize the phenotypic spectrum and functional consequences associated with variants in the gene GABRB2, coding for the γ-aminobutyric acid type A (GABAA ) receptor subunit β2. METHODS: We recruited and systematically evaluated 25 individuals with variants in GABRB2, 17 of whom are newly described and 8 previously reported with additional clinical data. Functional analysis was performed using a Xenopus laevis oocyte model system. RESULTS: Our cohort of 25 individuals from 22 families with variants in GABRB2 demonstrated a range of epilepsy phenotypes from genetic generalized epilepsy to developmental and epileptic encephalopathy. Fifty-eight percent of individuals had pharmacoresistant epilepsy; response to medications targeting the GABAergic pathway was inconsistent. Developmental disability (present in 84%) ranged from mild intellectual disability to severe global disability; movement disorders (present in 44%) included choreoathetosis, dystonia, and ataxia. Disease-associated variants cluster in the extracellular N-terminus and transmembrane domains 1-3, with more severe phenotypes seen in association with variants in transmembrane domains 1 and 2 and the allosteric binding site between transmembrane domains 2 and 3. Functional analysis of 4 variants in transmembrane domains 1 or 2 (p.Ile246Thr, p.Pro252Leu, p.Ile288Ser, p.Val282Ala) revealed strongly reduced amplitudes of GABA-evoked anionic currents. INTERPRETATION: GABRB2-related epilepsy ranges broadly in severity from genetic generalized epilepsy to developmental and epileptic encephalopathies. Developmental disability and movement disorder are key features. The phenotypic spectrum is comparable to other GABAA receptor-encoding genes. Phenotypic severity varies by protein domain. Experimental evidence supports loss of GABAergic inhibition as the mechanism underlying GABRB2-associated neurodevelopmental disorders. ANN NEUROL 2021;89:573-586.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. El Achkar CM, Harrer M, Smith L, et al. Characterization of the GABRB2-Associated Neurodevelopmental Disorders. Ann Neurol. 2020. PMID: 33325057. doi:10.1002/ana.25985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。